Dr. Reddy's Laboratories Files Routine 6-K Report
Ticker: RDY · Form: 6-K · Filed: Dec 6, 2024 · CIK: 1135951
| Field | Detail |
|---|---|
| Company | Dr Reddys Laboratories LTD (RDY) |
| Form Type | 6-K |
| Filed Date | Dec 6, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
DRL filed a 6-K, nothing major to see here.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on December 6, 2024, to report information as a foreign private issuer. The filing does not contain specific financial figures or material events beyond its routine reporting nature.
Why It Matters
This filing serves as a standard notification to the SEC by Dr. Reddy's Laboratories, a foreign private issuer, ensuring compliance with reporting requirements.
Risk Assessment
Risk Level: low — The filing is a routine report and does not disclose any new material information that would impact the company's risk profile.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001135951 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification
- 001-15182 (company) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the registrant may be required to disclose to any stock exchange on which its securities are or will be listed.
When was this Form 6-K filed?
This Form 6-K was filed on December 6, 2024.
What is the principal executive office address of Dr. Reddy's Laboratories Ltd.?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories Ltd. file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories Ltd. indicates that it files annual reports under cover of Form 20-F.
Does this filing contain specific financial results or material events?
Based on the provided text, this Form 6-K appears to be a routine filing and does not contain specific financial results or details of material events.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-12-06 06:11:55
Filing Documents
- drr0704_6k.htm (6-K) — 13KB
- drr0704_ex99-1.htm (EX-99.1) — 9KB
- drr0704_ex99-1img01.jpg (GRAPHIC) — 4KB
- drr0704_ex99-1img02.jpg (GRAPHIC) — 4KB
- 0001575872-24-001238.txt ( ) — 33KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: December 5, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3